Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
SEER Stock Forecast 2025-2026
$1.84
Current Price
$109.35M
Market Cap
Buy 1
Hold 2
Sell 0
Wall St Analyst Ratings
Distance to SEER Price Targets
+63.0%
To High Target of $3.00
+63.0%
To Median Target of $3.00
+63.0%
To Low Target of $3.00
SEER Price Momentum
-6.6%
1 Week Change
-8.0%
1 Month Change
-8.0%
1 Year Change
-20.3%
Year-to-Date Change
-29.9%
From 52W High of $2.63
+17.9%
From 52W Low of $1.56
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Seer (SEER) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on SEER and similar high-potential opportunities.
Latest SEER Stock Price Targets & Analyst Predictions
Based on our analysis of 5 Wall Street analysts, SEER has a neutral consensus with a median price target of $3.00 (ranging from $3.00 to $3.00). Currently trading at $1.84, the median forecast implies a 63.0% upside. This outlook is supported by 1 Buy, 2 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Yuko Oku at Morgan Stanley, projecting a 63.0% upside. Conversely, the most conservative target is provided by Yuko Oku at Morgan Stanley, suggesting a 63.0% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
SEER Analyst Ratings
1
Buy
2
Hold
0
Sell
SEER Price Target Range
Low
$3.00
Average
$3.00
High
$3.00
Current: $1.84
Latest SEER Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for SEER.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Aug 13, 2024 | Morgan Stanley | Yuko Oku | Equal-Weight | Maintains | $3.00 |
| Mar 5, 2024 | Morgan Stanley | Yuko Oku | Equal-Weight | Reinstates | $7.00 |
| Feb 21, 2023 | Morgan Stanley | Tejas Savant | Equal-Weight | Maintains | $10.00 |
| Jan 4, 2023 | B of A Securities | Derik De Bruin | Underperform | Downgrade | $6.50 |
| Nov 10, 2022 | Morgan Stanley | Tejas Savant | Equal-Weight | Maintains | $11.00 |
| Aug 11, 2022 | JP Morgan | Tycho Peterson | Neutral | Downgrade | $12.00 |
| Aug 11, 2022 | Morgan Stanley | Tejas Savant | Equal-Weight | Maintains | $14.00 |
| May 5, 2022 | Morgan Stanley | Tejas Savant | Equal-Weight | Maintains | $19.00 |
| Mar 1, 2022 | Morgan Stanley | Tejas Savant | Equal-Weight | Maintains | $21.00 |
| Feb 15, 2022 | Morgan Stanley | Equal-Weight | Maintains | $23.00 | |
| Aug 13, 2021 | Morgan Stanley | Tejas Savant | Equal-Weight | Maintains | $50.00 |
| May 12, 2021 | Morgan Stanley | Equal-Weight | Maintains | $55.00 | |
| Mar 30, 2021 | Morgan Stanley | Tejas Savant | Equal-Weight | Maintains | $60.00 |
| Dec 29, 2020 | Cowen & Co. | Outperform | Initiates | $0.00 | |
| Dec 29, 2020 | JP Morgan | Overweight | Initiates | $0.00 | |
| Dec 29, 2020 | Morgan Stanley | Equal-Weight | Initiates | $0.00 |
Seer Inc. (SEER) Competitors
The following stocks are similar to Seer based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Seer Inc. (SEER) Financial Data
Seer Inc. has a market capitalization of $109.35M with a P/E ratio of 0.0x. The company generates $14.17M in trailing twelve-month revenue with a 49.0% profit margin.
Revenue growth is -9.9% quarter-over-quarter, while maintaining an operating margin of -587.2% and return on equity of -23.9%.
Valuation Metrics
Market Cap
$109.35M
Enterprise Value
$-97,457,952
P/E Ratio
0.0x
PEG Ratio
-1.2x
Price/Sales
7.7x
Growth & Margins
Revenue Growth (YoY)
-9.9%
Gross Margin
+50.0%
Operating Margin
-587.2%
Net Margin
+49.0%
EPS Growth
-5.5%
Financial Health
Cash/Price Ratio
+214.9%
Current Ratio
16.5x
Debt/Equity
7.9x
ROE
-23.9%
ROA
-15.6%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Seer Inc. (SEER) Business Model
About Seer Inc.
What They Do
Develops innovative solutions for protein analysis.
Business Model
Seer Inc. generates revenue by providing high-throughput and scalable tools for protein analysis through its Proteograph Product Suite. This suite enhances biological research and supports advancements in personalized medicine, allowing researchers and clinicians to decode proteomic profiles, which can lead to improved therapeutic outcomes.
Additional Information
The company's technology is crucial in the healthcare and pharmaceuticals sectors, facilitating breakthroughs in disease diagnostics and therapy. By bridging the gap between genomics and proteomics, Seer Inc. empowers the life sciences market and contributes to the commercialization of research for practical healthcare applications.
Company Information
Sector
Healthcare
Industry
Biotechnology
Employees
134
CEO
Dr. Omid C. Farokhzad M.D., Ph.D.
Country
United States
IPO Year
2020
Website
seer.bioSeer Inc. (SEER) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates
AnaptysBio (ANAB) delivered earnings and revenue surprises of 1.54% and 52.31%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
May 05, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
Seer, Inc. (Nasdaq: SEER) will report its Q1 2025 financial results on May 13, 2025, as it focuses on advancing its proteomics platform.
Why It Matters
Seer, Inc.'s upcoming financial results announcement could impact stock performance, reflecting investor sentiment on its growth and the success of its proteomics platform.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Seer (SEER) is oversold, suggesting selling pressure may be easing. Analysts are raising earnings estimates, which could indicate a potential trend reversal for the stock.
Why It Matters
Seer’s oversold status and analysts’ upward earnings revisions suggest potential for price recovery, indicating a favorable buying opportunity for investors.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
Seer (SEER) is in oversold territory, with analysts revising earnings estimates upward, suggesting potential for a trend reversal.
Why It Matters
Seer (SEER) may be poised for recovery with signs of an oversold condition and analyst upgrades in earnings estimates, suggesting potential upside for investors.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
Seer (SEER) shows signs of being oversold, and Wall Street analysts are raising earnings estimates, suggesting a potential trend reversal for the stock.
Why It Matters
Seer (SEER) may be poised for a rebound due to oversold conditions and positive analyst earnings revisions, signaling potential upside for investors.
Source: Zacks Investment Research
Market Sentiment:
Positive
Seer, Inc. (SEER) Q4 2024 Earnings Call Transcript
2 months ago
Quick Summary
Seer, Inc. (NASDAQ:SEER) will hold its Q4 2024 earnings conference call on February 27, 2025, at 4:30 PM ET, featuring key executives and analysts from JPMorgan and Morgan Stanley.
Why It Matters
Seer, Inc.'s Q4 earnings call provides insights on financial performance and future guidance, impacting stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook
2 months ago
Quick Summary
Seer, Inc. (Nasdaq: SEER) announced its financial results for Q4 and the full year ending December 31, 2024, highlighting its advancements in proteomics technology.
Why It Matters
Seer, Inc.'s financial results can impact its stock price and investor sentiment, reflecting the company's growth potential and performance in the proteomics market.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About SEER Stock
What is Seer Inc.'s (SEER) stock forecast for 2025?
Based on our analysis of 5 Wall Street analysts, Seer Inc. (SEER) has a median price target of $3.00. The highest price target is $3.00 and the lowest is $3.00.
Is SEER stock a good investment in 2025?
According to current analyst ratings, SEER has 1 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.84. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for SEER stock?
Wall Street analysts predict SEER stock could reach $3.00 in the next 12 months. This represents a 63.0% increase from the current price of $1.84. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Seer Inc.'s business model?
Seer Inc. generates revenue by providing high-throughput and scalable tools for protein analysis through its Proteograph Product Suite. This suite enhances biological research and supports advancements in personalized medicine, allowing researchers and clinicians to decode proteomic profiles, which can lead to improved therapeutic outcomes.
What is the highest forecasted price for SEER Seer Inc.?
The highest price target for SEER is $3.00 from Yuko Oku at Morgan Stanley, which represents a 63.0% increase from the current price of $1.84.
What is the lowest forecasted price for SEER Seer Inc.?
The lowest price target for SEER is $3.00 from Yuko Oku at Morgan Stanley, which represents a 63.0% increase from the current price of $1.84.
What is the overall SEER consensus from analysts for Seer Inc.?
The overall analyst consensus for SEER is neutral. Out of 5 Wall Street analysts, 1 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $3.00.
How accurate are SEER stock price projections?
Stock price projections, including those for Seer Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 12, 2025 5:03 AM UTC